Proteins as biomarkers of carbon monoxide neurotoxicity

References

• Annane D, Chevret S, Jars-Guincestre C, et al. (2001). Prognostic factors in unintentional mild carbon monoxide poisoning. Intensive Care Med 27:1776–81
   PubMed Web of Science ®Google Scholar
• Avila J, Lucas JJ, Pérez M, Hernández F. (2004). Role of tau protein in both physiological and pathological conditions. Physiol Rev 84:361–84
   PubMed Web of Science ®Google Scholar
• Bitsch A, Horn C, Kemmling Y, et al. (2002). Serum tau protein level as a marker of axonal damage in acute ischemic stroke. Eur Neurol 47:45–51
   PubMed Web of Science ®Google Scholar
• Brvar M, Možina H, Osredkar J, et al. (2004). S100B protein in carbon monoxide poisoning: a pilot study. Resuscitation 61:357–60
   PubMed Web of Science ®Google Scholar
• Cakir Z, Aslan S, Umudum Z, et al. (2010). S-100beta and neuron-specific enolase levels in carbon monoxide-related brain injury. Am J Emerg Med 28:61–7
   PubMed Web of Science ®Google Scholar
• Chu K, Jung KH, Kim HJ, et al. (2004). Diffusion-weighted MRI and 99mTc-HMPAO SPECT in delayed relapsing type of carbon monoxide poisoning: evidence of delayed cytotoxic edema. Eur Neurol 51:98–103
   PubMed Web of Science ®Google Scholar
• Cronje FJ, Carraway MS, Freiberger JJ, et al. (2004). Carbon monoxide actuates O(2)-limited heme degradation in the rat brain. Free Radic Biol Med 37:1802–12
   PubMed Web of Science ®Google Scholar
• Drubin DG, Kirschner MW. (1986). Tau protein function in living cells. J Cell Biol 103:2739–46
   PubMed Web of Science ®Google Scholar
• Foerch C, Singer OC, Neumann-Haefelin T, et al. (2005). Evaluation of serum S100B as a surrogate marker for long-term outcome and infarct volume in acute middle cerebral artery infarction. Arch Neurol 62:1130–4
   PubMed Web of Science ®Google Scholar
• Gawlikowski T, Gomolka E, Piekoszewski W, et al. (2013). Acute CO poisoning is associated with impaired fibrinolysis and increased thrombin generation. Basic Clin Pharmacol Toxicol 112:352–6
   PubMed Web of Science ®Google Scholar
• Gonçalves CA, Leite M, Nardin P. (2008). Biological and methodological features of the measurement of S100B, a putative marker of brain injury. Clin Biochem 41:755–63
   PubMed Web of Science ®Google Scholar
• Gorman D, Drewry A, Huang YL, Sames C. (2003). The clinical toxicology of carbon monoxide. Toxicology 187:25–38
   PubMed Web of Science ®Google Scholar
• Henry CR, Satran D, Lindgren B, et al. (2006). Myocardial injury and long-term mortality following moderate to severe carbon monoxide poisoning. JAMA 295:398–402
   PubMed Web of Science ®Google Scholar
• Hu H, Pan X, Wan Y, et al. (2011). Factors affecting the prognosis of patients with delayed encephalopathy after acute carbon monoxide poisoning. Am J Emerg Med 29:261–4
   PubMed Web of Science ®Google Scholar
• Hu HT, Xiao F, Yan YQ, et al. (2012). The prognostic value of serum tau in patients with intracerebral hemorrhage. Clin Biochem 45:1320–4
   PubMed Web of Science ®Google Scholar
• Ide T, Kamijo Y, Ide A, et al. (2012). Elevated S100B level in cerebrospinal fluid could predict poor outcome of carbon monoxide poisoning. Am J Emerg Med 30:222–5
   PubMed Web of Science ®Google Scholar
• Iqbal S, Law HZ, Clower JH, et al. (2012). Hospital burden of unintentional carbon monoxide poisoning in the United States. Am J Emerg Med 30:657–64
   PubMed Web of Science ®Google Scholar
• Kilicaslan I, Bildik F, Aksel G, et al. (2012). Serum tau protein level for neurological injuries in carbon monoxide poisoning. Clin Toxicol 50:497–502
   PubMed Web of Science ®Google Scholar
• Kim JH, Chang KH, Song IC, et al. (2003). Delayed encephalopathy of acute carbon monoxide intoxication: diffusivity of cerebral white matter lesions. Am J Neuroradiol 24:1592–7
   PubMed Web of Science ®Google Scholar
• Li X, Kumar Y, Zempel H, et al. (2011). Novel diffusion barrier for axonal retention of Tau in neurons and its failure in neurodegeneration. EMBO J 30:4825–37
   PubMed Web of Science ®Google Scholar
• Liliang PC, Liang CL, Lu K, et al. (2010). Relationship between injury severity and serum tau protein levels in traumatic brain injured rats. Resuscitation 81:1205–8
   PubMed Web of Science ®Google Scholar
• Lippi G, Rastelli G, Meschi T, et al. (2012). Pathophysiology, clinics, diagnosis and treatment of heart involvement in carbon monoxide poisoning. Clin Biochem 45:1278–85
   PubMed Web of Science ®Google Scholar
• Mandelkow EM, Mandelkow E. (2012). Biochemistry and cell biology of tau protein in neurofibrillary degeneration. Cold Spring Harb Perspect Med 2:a006247
   PubMed Web of Science ®Google Scholar
• Moon JM, Shin MH, Chun BJ. (2011). The value of initial lactate in patients with carbon monoxide intoxication: in the emergency department. Hum Exp Toxicol 30:836–43
   PubMed Web of Science ®Google Scholar
• Omaye ST. (2002). Metabolic modulation of carbon monoxide toxicity. Toxicology 180:139–50
   PubMed Web of Science ®Google Scholar
• Park E, Ahn J, Min YG, et al. (2012). The usefulness of the serum s100b protein for predicting delayed neurological sequelae in acute carbon monoxide poisoning. Clin Toxicol 50:183–8
   PubMed Web of Science ®Google Scholar
• Parkinson RB, Hopkins RO, Cleavinger HB, et al. (2002). White matter hyperintensities and neuropsychological outcome following carbon monoxide poisoning. Neurology 58:1525–32
   PubMed Web of Science ®Google Scholar
• Rasmussen LS, Poulsen MG, Christiansen M, Jansen EC. (2004). Biochemical markers for brain damage after carbon monoxide poisoning. Acta Anaesthesiol Scand 48:469–73
   PubMed Web of Science ®Google Scholar
• Sakatani S, Seto-Ohshima A, Shinohara Y, et al. (2008). Neural-activity-dependent release of S100B from astrocytes enhances kainate-induced gamma oscillations in vivo. J Neurosci 28:10928–36
   PubMed Web of Science ®Google Scholar
• Sen J, Belli A. (2007). S100B in neuropathologic states: the CRP of the brain? J Neurosci Res 85:1373–80
   PubMed Web of Science ®Google Scholar
• Shakeri M, Mahdkhah A, Panahi F. (2013). S100B protein as a post-traumatic biomarker for prediction of brain death in association with patient outcomes. Arch Trauma Res 2:76–80
   PubMedGoogle Scholar
• Shankland SJ. (2006). The podocyte's response to injury: role in proteinuria and glomerulosclerosis. Kidney Int 69:2131–47
   PubMed Web of Science ®Google Scholar
• Shaw GJ, Jauch EC, Zemlan FP. (2002). Serum cleaved tau protein levels and clinical outcome in adult patients with closed head injury. Ann Emerg Med 39:254–57
   PubMed Web of Science ®Google Scholar
• Souter S, Lee G. (2009). Microtubule-associated protein tau in human prostate cancer cells: isoforms, phosphorylation, and interactions. J Cell Biochem 108:555–64
   PubMed Web of Science ®Google Scholar
• Sparks DL, Kryscio RJ, Sabbagh MN, et al. (2012). Tau is reduced in AD plasma and validation of employed ELISA methods. Am J Neurodegener Dis 1:99–106
   PubMedGoogle Scholar
• Thelin EP, Nelson DW, Bellander BM. (2014). Secondary peaks of S100B in serum relate to subsequent radiological pathology in traumatic brain injury. Neurocrit Care 20:217–29
   PubMed Web of Science ®Google Scholar
• Thom SR, Bhopale VM, Fisher D. (2006a). Hyperbaric oxygen reduces delayed immune-mediated neuropathology in experimental carbon monoxide toxicity. Toxicol Appl Pharmacol 213:152–9
   PubMed Web of Science ®Google Scholar
• Thom SR, Bhopale VM, Han ST, et al. (2006b). Intravascular neutrophil activation due to carbon monoxide poisoning. Am J Respir Crit Care Med 174:1239–48
   PubMed Web of Science ®Google Scholar
• Trojanowski JQ, Lee VM. (2002). The role of tau in Alzheimer's disease. Med Clin North Am 86:615–27
   PubMed Web of Science ®Google Scholar
• Wang K, Deng QT, Liao N, et al. (2013a). Tau expression correlated with breast cancer sensitivity to taxanes-based neoadjuvant chemotherapy. Tumour Biol 34:33–8
   PubMedGoogle Scholar
• Wang Q, Wang N, Shao G, et al. (2013b). Relationship between gastric cancer tau protein expression and paclitaxel sensitivity. Pathol Oncol Res 19:429–35
   PubMed Web of Science ®Google Scholar
• Wojtczak-Soska K, Lelonek M. (2010). S-100B protein: An early prognostic marker after cardiac arrest. Cardiol J 17:532–6
   PubMed Web of Science ®Google Scholar
• Wunderlich MT, Lins H, Skalej M, et al. (2006). Neuron-specific enolase and tau protein as neurobiochemical markers of neuronal damage are related to early clinical course and long-term outcome in acute ischemic stroke. Clin Neurol Neurosurg 108:558–63
   PubMed Web of Science ®Google Scholar
• Yardan T, Cevik Y, Donderici O, et al. (2009). Elevated serum S100B protein and neuron-specific enolase levels in carbon monoxide poisoning. Am J Emerg Med 27:838–42
   PubMed Web of Science ®Google Scholar
• Yokobori S, Hosein K, Burks S, et al. (2013). Biomarkers for the clinical differential diagnosis in traumatic brain injury – a systematic review. CNS Neurosci Ther 19:556–65
   PubMed Web of Science ®Google Scholar
• Zemlan FP, Rosenberg WS, Luebbe PA, et al. (1999). Quantification of axonal damage in traumatic brain injury: affinity purification and characterization of cerebrospinal fluid Tau proteins. J Neurochem 72:741–50
   PubMed Web of Science ®Google Scholar
• Zetterberg H, Wilson D, Andreasson U, et al. (2013). Plasma tau levels in Alzheimer's disease. Alzheimers Res Ther 5:9
   PubMed Web of Science ®Google Scholar